Signal: Eli Lilly’s $176.5m Teva patent infringement loss overturned in US
A District Judge overturned last year's jury verdict, declaring the application of Teva's patents overly broad.
Insights
Signal: AbbVie ends multi-million dollar cancer drug deal with I-Mab
Signal: CMR Surgical Raises $165m to continue development of surgical robot
Signal: Fresh Tracks nears end of operations with plans for dissolution
Signal: UK NHS pay row intensifies as doctors launch joint strike
Signal: Illumina leads $15m investment in Broken String Biosciences
Signal: Roche to refile subcutaneous Tecentriq with FDA after UK approval
Signal: Kroger to pay up to $1.4bn to settle opioid crisis lawsuits
Deals
View More
Jobs
View More
Filings
View More
Patents
View More
